Albemarle Corp buy BMO Capital Markets
Start price
16.12.25
/
50%
€112.78
Target price
16.12.26
€123.40
Performance (%)
21.97%
Price
10:55
€137.56
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 21.97%. This prediction currently runs until 16.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Albemarle Corp | 9.734% |
| iShares Core DAX® | 1.822% |
| iShares Nasdaq 100 | 1.093% |
| iShares Nikkei 225® | 3.042% |
| iShares S&P 500 | 1.247% |
Comments by BMO_Capital_Markets for this prediction
In the thread Albemarle Corp diskutieren
Albemarle (NYSE:ALB) had its price target raised by analysts at BMO Capital Markets from $136.00 to $145.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Albemarle Corp
Albemarle Corp
Start price
Target price
Perf. (%)
€114.90
07.11.23
07.11.23
€168.34
07.11.24
07.11.24
-19.53%
08.11.24
08.11.24
